The various signaling pathways involved in maintaining the GBM-derived stem cells (GSCs) stemness, mitogenic capacity and anti-apoptotic properties which make the PDK1/AKT pathway a challenging target for the development of innovative potential medications able to alter GBM resistance to chemotherapy. The gene discussed is PDK1; the disease is glioblastoma.